Annual Drug Patent Expirations for QINLOCK
Qinlock is a drug marketed by Deciphera Pharms and is included in one NDA. It is available from one supplier. There are twenty-eight patents protecting this drug.
This drug has seventy-nine patent family members in twenty-three countries.
The generic ingredient in QINLOCK is ripretinib. One supplier is listed for this compound. Additional details are available on the ripretinib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
